Appendix D: Draft Telehealth Clinical Services Agreement
Draft Telehealth Clinical Services Agreement — peptide prescribing platforms.
Traves Brady
Tech & Healthcare Entrepreneur - Built multiple companies from napkin to 8 figure revenues
Appendix C: Draft API Supply Agreement
Draft API Supply Agreement — Active Pharmaceutical Ingredients for lawful compounding use.
Appendix B: Draft 503B Outsourcing Facility Services Agreement
Draft 503B Outsourcing Facility Services Agreement — office-use sterile compounding.
Appendix A: Draft Pharmacy Services Agreement (503A)
Draft 503A Pharmacy Services Agreement — patient-specific compounding arrangements.
Mini-Handbook Appendices
Five draft agreement templates for peptide operators — 503A Pharmacy, 503B Outsourcing, API Supply, Telehealth, and Supplier Evaluation Checklist.
Supply Chain
Why Peptide Manufacturers Cannot Grant Distribution Rights — And the Correct Agreement Framework
The phrase "distribution agreement" is almost always the wrong framework for a peptide business. A Red/Yellow/Green field guide and the five correct agreement types — with draft templates available to AEG Members.
Monthly Compliance Digest — April 2026
The Compliance Membership — What's In Your Member Resources
How to Read an FDA 483 Observation (And What It Means for Your Business)
The FDA Enforcement Pattern Nobody Is Talking About (And Why It Should Change How You Operate)
Supply Chain Audit: The 14 Questions Every Peptide Operator Should Ask Their Supplier
The Four Legal Lanes Peptide Businesses Actually Operate In
Most peptide operators don't know which lane they're in. That's not a knock — the regulatory landscape is genuinely complex, and most guidance is written for lawyers, not founders. This is a framework built for operators. Why "Which Lane?" Is the First Question